Investors appeared disappointed by a sharply front-loaded earnings downturn and cautious recovery profile, sending Campbell’s shares down 10.1% after earnings. Management expects organic sales to decline about 3% at the midpoint, gross margin to fall 50–100 basis points for the year, and EPS to decline sharply in Q1 before improving only gradually.
Campbell's shares edged up modestly by 2.1%, reflecting a cautious reception to ongoing cost pressures and cautious commentary around inflation and portfolio rationalization without clear near-term catalysts to drive stronger upside.
Campbell Soup Company reported a challenging Q2 2026, with a 6% decline in net sales leading to a significant drop in snack segment margins.